Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
Genetic modifiers of p53: opportunities for breast cancer therapies.
Leukoplakia
Response to comment on "IgH chain class switch recombination: mechanism and regulation".
See All 4 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Genetic modifiers of p53: opportunities for breast cancer therapies.
Majhi PD, Sharma A, Jerry DJ. Genetic modifiers of p53: opportunities for breast cancer therapies. Oncotarget. 2023 03 24; 14:236-241.
View in:
PubMed
subject areas
Breast Neoplasms
Female
Genes, p53
Genetic Predisposition to Disease
Germ-Line Mutation
Humans
Li-Fraumeni Syndrome
Tumor Suppressor Protein p53
authors with profiles
D Joseph Jerry BS, MS, PhD